Surveillance of initial drug resistance
Overall Purpose: to assess initial drug-resistant HIV among children < 18 months of age and newly diagnosed with HIV in resource-limited countries in order to inform selection of first-line ART regimens for this population in each participating country and support global decision-making on regimens for this population.
Objectives
- To describe the prevalence of initial NNRTI (non-nucleoside reverse transcriptase inhibitor) and NRTI (nucleoside reverse transcriptase inhibitor) resistance in children newly diagnosed with HIV who are < 18 months of age
- To describe the prevalence of initial NNRTI and NRTI resistance in children newly diagnosed with HIV who are < 18 months of age and whose previous ARV exposure is recorded as “none” or “unknown